Healthcare Medical Devices Biotechnology

Cell Culture Market is Expected to Reach USD 60.03 Billion by 2030

Mar 2024

Healthcare Medical Devices Biotechnology

As per the report published by Kings Research, the global Cell Culture Market was valued at USD 26.96 billion in 2022 and is projected to reach USD 60.03 billion by 2030, growing at a CAGR of 10.59% from 2023 to 2030.

The rise of precision medicine and personalized therapies is a key factor driving the global cell culture market growth. This trend has created a strong demand for cell cultures that are specific to each patient, as they are crucial in developing personalized treatments. As the healthcare sector increasingly focuses on providing customized solutions for individual patients, there is a growing need for advanced cell culture technologies and techniques. This surge in demand is pushing the market to develop and adapt in order to meet the evolving requirements of personalized medicine and therapy development.

Key Insights

  • Based on product type, the instruments & accessories segment held the largest market share of 78.56% in 2022
  • Based on cell type, the microbial cells segment generated the highest revenue of USD 11.96 billion in 2022
  • Based on application, the biopharmaceutical production segment accounted for the largest revenue share of 30.82% in 2022
  • Based on end-user, the research institutes and academia segment is set to grow at the highest CAGR of 14.62% over the forecast period
  • On the basis of region, North America accounted for the largest market share of 33.52% in 2022

Canon Expands into Regenerative Medicine through Cell Therapy Company Acquisition

March 2023: Canon Inc. entered the regenerative medicine field by acquiring a cell therapy company. This move aligned with Canon's strategic diversification efforts, expanding its presence in the growing biotechnology sector. The acquisition was a strategic step into the cell culture market, where Canon aimed to leverage its technological expertise to advance cell-based therapies and regenerative medicine applications.

AI and Machine Learning to Support Cell Culture Market Growth

The integration of artificial intelligence (AI) and machine learning (ML) stands as a pivotal factor fueling the cell culture market progress. These advanced technologies are reshaping the landscape by optimizing cell culture processes, offering predictive insights into outcomes, and enhancing data analysis. By leveraging AI and ML, researchers and biopharmaceutical companies gain powerful tools for optimizing bioprocesses, improving product quality, and increasing efficiency. This transformative driver is accelerating the pace of research, reducing costs, and playing a central role in the quest for innovative cell-based therapies and biopharmaceutical production, ultimately propelling the cell culture market expansion.

Incorporation of Automation and High-Throughput Technologies in Cell Culture to Present Significant Growth Opportunities

Automation and high-throughput technologies present a lucrative growth opportunity in the cell culture industry. As biopharmaceutical production and cell-based research expand, the need for streamlined and efficient processes is growing. Automation, including robotic systems and automated bioreactors, enhances productivity and reduces manual labor, making large-scale production more feasible. High-throughput technologies enable simultaneous testing of multiple samples, thereby accelerating research and development efforts. With the growing demand for biopharmaceuticals and cell-based therapies, companies investing in these technologies can gain a competitive edge. Furthermore, automation and high-throughput systems improve data quality, reduce operational costs, and enhance the reproducibility and scalability of cell culture processes, positioning them as a key factor driving market growth.

Asia Pacific is Poised to become the Fastest Growing Region in the Market with a Projected CAGR of 14.73%

Asia Pacific is emerging as a dynamic and rapidly growing region in the global cell culture market. The region is experiencing a substantial increase in healthcare investment and research and development activities, which underpins its growing influence in the biopharmaceutical and biotechnology sectors. The region offers a vast and skilled workforce, which is essential for expanding cell culture research and manufacturing capabilities. Additionally, the region's strategic focus on innovative biotechnology and pharmaceutical developments, combined with a rising interest in cell culture technologies and applications, positions it as a major region in the global market.

Companies to Focus on Launching Cutting-Edge Products to Extend Their Reach

The global cell culture market is fragmented with significant players, such as Thermo Fisher Scientific, Inc., Merck KGaA, Becton, Dickinson and Company (BD), Lonza Group AG, GE Healthcare, Sartorius AG, Corning Incorporated, Promega Corporation, Eppendorf AG, Fujifilm Holdings Corporation, and others. These companies concentrate on expanding their business through collaboration and partnership strategies, while also launching cutting-edge products to grow their customer base.

Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership